Back

Immunome announces IND clearance for IM-1340 solid-tumor treatment

Verifying
  • Immunome announced IND clearance for IM-1340.
  • IM-1340 is described as a potential first-in-class antibody-drug conjugate.
  • The candidate is intended for the treatment of solid tumors.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.